IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sands Capital Alternatives, LLC

Q2 2025 Holdings

Filed 2025-08-13 | 19 holdings | $507.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Klaviyo Inc(KVYO)COM SER A49845K101$118.0M3,515,06523.2%
NU Hldgs LTD(NU)ORD SHS CL AG6683N103$98.4M7,175,43419.4%
Doordash Inc(DASH)CL A25809K105$94.0M381,20218.5%
Beta Bionics Inc(BBNX)COM08659B102$52.0M3,570,11310.2%
Coupang Inc(CPNG)CL A22266T109$25.4M849,0315.0%
Inhibikase Therapeutics Inc(IKT)COM NEW45719W205$21.4M10,950,0004.2%
Monday COM LTD(MNDY)SHSM7S64H106$18.3M58,3363.6%
Samsara Inc(IOT)COM CL A79589L106$17.4M438,4853.4%
Datadog Inc(DDOG)CL A COM23804L103$15.9M118,7073.1%
Crowdstrike Hldgs Inc(CRWD)CL A22788C105$8.0M15,6151.6%
Toast Inc(TOST)CL A888787108$6.9M156,6041.4%
Tarsus Pharmaceuticals Inc(TARS)COM87650L103$6.9M170,0001.4%
Snowflake Inc(SNOW)CL A833445109$6.0M27,0051.2%
10X Genomics Inc(TXG)CL A COM88025U109$5.6M481,7701.1%
Acumen Pharmaceuticals Inc(ABOS)COM00509G209$4.0M3,417,0750.8%
Bioage Labs Inc(BIOA)COM09077V100$3.2M786,3530.6%
Acrivon Therapeutics Inc(ACRV)COMMON STOCK004890109$2.5M2,122,6050.5%
Candel Therapeutics Inc(CADL)COM137404109$2.1M405,8370.4%
Taysha Gene Therapies Inc(TSHA)COM SHS877619106$1.7M724,8730.3%